ZOETIS INC (ZTS) Fundamental Analysis & Valuation

NYSE:ZTS • US98978V1035

Current stock price

122.38 USD
+3.34 (+2.81%)
At close:
122.38 USD
0 (0%)
After Hours:

This ZTS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

9

1. ZTS Profitability Analysis

1.1 Basic Checks

  • In the past year ZTS was profitable.
  • In the past year ZTS had a positive cash flow from operations.
  • In the past 5 years ZTS has always been profitable.
  • ZTS had a positive operating cash flow in each of the past 5 years.
ZTS Yearly Net Income VS EBIT VS OCF VS FCFZTS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

1.2 Ratios

  • The Return On Assets of ZTS (17.28%) is better than 95.81% of its industry peers.
  • ZTS has a better Return On Equity (80.25%) than 99.48% of its industry peers.
  • The Return On Invested Capital of ZTS (21.95%) is better than 97.38% of its industry peers.
  • ZTS had an Average Return On Invested Capital over the past 3 years of 22.23%. This is significantly above the industry average of 13.11%.
Industry RankSector Rank
ROA 17.28%
ROE 80.25%
ROIC 21.95%
ROA(3y)17.05%
ROA(5y)15.99%
ROE(3y)59.76%
ROE(5y)54.42%
ROIC(3y)22.23%
ROIC(5y)21.04%
ZTS Yearly ROA, ROE, ROICZTS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

1.3 Margins

  • With an excellent Profit Margin value of 28.23%, ZTS belongs to the best of the industry, outperforming 93.72% of the companies in the same industry.
  • ZTS's Profit Margin has improved in the last couple of years.
  • ZTS has a better Operating Margin (38.54%) than 97.38% of its industry peers.
  • ZTS's Operating Margin has improved in the last couple of years.
  • ZTS has a better Gross Margin (71.89%) than 79.06% of its industry peers.
  • In the last couple of years the Gross Margin of ZTS has remained more or less at the same level.
Industry RankSector Rank
OM 38.54%
PM (TTM) 28.23%
GM 71.89%
OM growth 3Y1.57%
OM growth 5Y2.33%
PM growth 3Y2.57%
PM growth 5Y2.85%
GM growth 3Y1.04%
GM growth 5Y0.73%
ZTS Yearly Profit, Operating, Gross MarginsZTS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. ZTS Health Analysis

2.1 Basic Checks

  • ZTS has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • ZTS has less shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, ZTS has less shares outstanding
  • ZTS has a worse debt/assets ratio than last year.
ZTS Yearly Shares OutstandingZTS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M
ZTS Yearly Total Debt VS Total AssetsZTS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.2 Solvency

  • An Altman-Z score of 5.47 indicates that ZTS is not in any danger for bankruptcy at the moment.
  • ZTS has a better Altman-Z score (5.47) than 72.77% of its industry peers.
  • ZTS has a debt to FCF ratio of 3.96. This is a good value and a sign of high solvency as ZTS would need 3.96 years to pay back of all of its debts.
  • The Debt to FCF ratio of ZTS (3.96) is better than 86.39% of its industry peers.
  • A Debt/Equity ratio of 2.71 is on the high side and indicates that ZTS has dependencies on debt financing.
  • With a Debt to Equity ratio value of 2.71, ZTS is not doing good in the industry: 83.25% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 2.71
Debt/FCF 3.96
Altman-Z 5.47
ROIC/WACC2.45
WACC8.96%
ZTS Yearly LT Debt VS Equity VS FCFZTS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.3 Liquidity

  • A Current Ratio of 3.03 indicates that ZTS has no problem at all paying its short term obligations.
  • The Current ratio of ZTS (3.03) is comparable to the rest of the industry.
  • A Quick Ratio of 1.94 indicates that ZTS should not have too much problems paying its short term obligations.
  • The Quick ratio of ZTS (1.94) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 3.03
Quick Ratio 1.94
ZTS Yearly Current Assets VS Current LiabilitesZTS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. ZTS Growth Analysis

3.1 Past

  • ZTS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 8.45%, which is quite good.
  • Measured over the past years, ZTS shows a quite strong growth in Earnings Per Share. The EPS has been growing by 10.77% on average per year.
  • Looking at the last year, ZTS shows a small growth in Revenue. The Revenue has grown by 2.28% in the last year.
  • Measured over the past years, ZTS shows a small growth in Revenue. The Revenue has been growing by 7.24% on average per year.
EPS 1Y (TTM)8.45%
EPS 3Y9.57%
EPS 5Y10.77%
EPS Q2Q%5.71%
Revenue 1Y (TTM)2.28%
Revenue growth 3Y5.42%
Revenue growth 5Y7.24%
Sales Q2Q%3.02%

3.2 Future

  • The Earnings Per Share is expected to grow by 7.80% on average over the next years.
  • The Revenue is expected to grow by 5.30% on average over the next years.
EPS Next Y10.17%
EPS Next 2Y8.84%
EPS Next 3Y8.56%
EPS Next 5Y7.8%
Revenue Next Year4.91%
Revenue Next 2Y4.88%
Revenue Next 3Y4.85%
Revenue Next 5Y5.3%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ZTS Yearly Revenue VS EstimatesZTS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B 8B 10B
ZTS Yearly EPS VS EstimatesZTS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

6

4. ZTS Valuation Analysis

4.1 Price/Earnings Ratio

  • ZTS is valuated rather expensively with a Price/Earnings ratio of 19.06.
  • 84.29% of the companies in the same industry are more expensive than ZTS, based on the Price/Earnings ratio.
  • Compared to an average S&P500 Price/Earnings ratio of 27.87, ZTS is valued a bit cheaper.
  • Based on the Price/Forward Earnings ratio of 17.30, the valuation of ZTS can be described as rather expensive.
  • ZTS's Price/Forward Earnings ratio is rather cheap when compared to the industry. ZTS is cheaper than 80.63% of the companies in the same industry.
  • ZTS is valuated cheaply when we compare the Price/Forward Earnings ratio to 38.51, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 19.06
Fwd PE 17.3
ZTS Price Earnings VS Forward Price EarningsZTS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • 82.72% of the companies in the same industry are more expensive than ZTS, based on the Enterprise Value to EBITDA ratio.
  • ZTS's Price/Free Cash Flow ratio is rather cheap when compared to the industry. ZTS is cheaper than 84.29% of the companies in the same industry.
Industry RankSector Rank
P/FCF 22.63
EV/EBITDA 13.78
ZTS Per share dataZTS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ZTS does not grow enough to justify the current Price/Earnings ratio.
  • ZTS has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)1.88
PEG (5Y)1.77
EPS Next 2Y8.84%
EPS Next 3Y8.56%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

7

5. ZTS Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 1.64%, ZTS has a reasonable but not impressive dividend return.
  • ZTS's Dividend Yield is rather good when compared to the industry average which is at 0.42. ZTS pays more dividend than 92.15% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.82, ZTS has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 1.64%

5.2 History

  • On average, the dividend of ZTS grows each year by 20.56%, which is quite nice.
  • ZTS has been paying a dividend for at least 10 years, so it has a reliable track record.
  • ZTS has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)20.56%
Div Incr Years12
Div Non Decr Years12
ZTS Yearly Dividends per shareZTS Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5

5.3 Sustainability

  • 33.26% of the earnings are spent on dividend by ZTS. This is a low number and sustainable payout ratio.
  • The dividend of ZTS is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP33.26%
EPS Next 2Y8.84%
EPS Next 3Y8.56%
ZTS Yearly Income VS Free CF VS DividendZTS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B
ZTS Dividend Payout.ZTS Dividend Payout, showing the Payout Ratio.ZTS Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

ZTS Fundamentals: All Metrics, Ratios and Statistics

ZOETIS INC

NYSE:ZTS (4/17/2026, 8:04:00 PM)

After market: 122.38 0 (0%)

122.38

+3.34 (+2.81%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)02-12
Earnings (Next)05-07
Inst Owners101.23%
Inst Owner Change0.02%
Ins Owners0.07%
Ins Owner Change3.93%
Market Cap51.46B
Revenue(TTM)9.47B
Net Income(TTM)2.67B
Analysts76.8
Price Target150.27 (22.79%)
Short Float %3.59%
Short Ratio3.64
Dividend
Industry RankSector Rank
Dividend Yield 1.64%
Yearly Dividend2.04
Dividend Growth(5Y)20.56%
DP33.26%
Div Incr Years12
Div Non Decr Years12
Ex-Date04-20
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)4.16%
Min EPS beat(2)3.79%
Max EPS beat(2)4.53%
EPS beat(4)4
Avg EPS beat(4)5.31%
Min EPS beat(4)3.79%
Max EPS beat(4)7.75%
EPS beat(8)8
Avg EPS beat(8)4.82%
EPS beat(12)10
Avg EPS beat(12)3.31%
EPS beat(16)12
Avg EPS beat(16)3.06%
Revenue beat(2)1
Avg Revenue beat(2)-0.66%
Min Revenue beat(2)-1.44%
Max Revenue beat(2)0.13%
Revenue beat(4)3
Avg Revenue beat(4)0.04%
Min Revenue beat(4)-1.44%
Max Revenue beat(4)1.11%
Revenue beat(8)6
Avg Revenue beat(8)0.76%
Revenue beat(12)6
Avg Revenue beat(12)0.17%
Revenue beat(16)7
Avg Revenue beat(16)-0.2%
PT rev (1m)-3.34%
PT rev (3m)-7.85%
EPS NQ rev (1m)0.05%
EPS NQ rev (3m)2.86%
EPS NY rev (1m)-0.07%
EPS NY rev (3m)3.5%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.34%
Revenue NY rev (1m)-0.01%
Revenue NY rev (3m)-0.07%
Valuation
Industry RankSector Rank
PE 19.06
Fwd PE 17.3
P/S 5.46
P/FCF 22.63
P/OCF 17.79
P/B 15.51
P/tB N/A
EV/EBITDA 13.78
EPS(TTM)6.42
EY5.25%
EPS(NY)7.07
Fwd EY5.78%
FCF(TTM)5.41
FCFY4.42%
OCF(TTM)6.88
OCFY5.62%
SpS22.43
BVpS7.89
TBVpS-1.03
PEG (NY)1.88
PEG (5Y)1.77
Graham Number33.7616 (-72.41%)
Profitability
Industry RankSector Rank
ROA 17.28%
ROE 80.25%
ROCE 27.58%
ROIC 21.95%
ROICexc 26.6%
ROICexgc 40.59%
OM 38.54%
PM (TTM) 28.23%
GM 71.89%
FCFM 24.12%
ROA(3y)17.05%
ROA(5y)15.99%
ROE(3y)59.76%
ROE(5y)54.42%
ROIC(3y)22.23%
ROIC(5y)21.04%
ROICexc(3y)26.94%
ROICexc(5y)27.11%
ROICexgc(3y)44.63%
ROICexgc(5y)48.4%
ROCE(3y)27.92%
ROCE(5y)26.43%
ROICexgc growth 3Y-11.38%
ROICexgc growth 5Y-5.24%
ROICexc growth 3Y-2.74%
ROICexc growth 5Y2.7%
OM growth 3Y1.57%
OM growth 5Y2.33%
PM growth 3Y2.57%
PM growth 5Y2.85%
GM growth 3Y1.04%
GM growth 5Y0.73%
F-Score6
Asset Turnover0.61
Health
Industry RankSector Rank
Debt/Equity 2.71
Debt/FCF 3.96
Debt/EBITDA 2.19
Cap/Depr 127.52%
Cap/Sales 6.56%
Interest Coverage 13.98
Cash Conversion 70.21%
Profit Quality 85.41%
Current Ratio 3.03
Quick Ratio 1.94
Altman-Z 5.47
F-Score6
WACC8.96%
ROIC/WACC2.45
Cap/Depr(3y)136.13%
Cap/Depr(5y)128.18%
Cap/Sales(3y)7.4%
Cap/Sales(5y)7.12%
Profit Quality(3y)82.33%
Profit Quality(5y)78.99%
High Growth Momentum
Growth
EPS 1Y (TTM)8.45%
EPS 3Y9.57%
EPS 5Y10.77%
EPS Q2Q%5.71%
EPS Next Y10.17%
EPS Next 2Y8.84%
EPS Next 3Y8.56%
EPS Next 5Y7.8%
Revenue 1Y (TTM)2.28%
Revenue growth 3Y5.42%
Revenue growth 5Y7.24%
Sales Q2Q%3.02%
Revenue Next Year4.91%
Revenue Next 2Y4.88%
Revenue Next 3Y4.85%
Revenue Next 5Y5.3%
EBIT growth 1Y7.54%
EBIT growth 3Y7.08%
EBIT growth 5Y9.74%
EBIT Next Year18.61%
EBIT Next 3Y9.66%
EBIT Next 5Y8.5%
FCF growth 1Y-0.65%
FCF growth 3Y19.85%
FCF growth 5Y6.41%
OCF growth 1Y-1.66%
OCF growth 3Y14.95%
OCF growth 5Y6.44%

ZOETIS INC / ZTS Fundamental Analysis FAQ

What is the ChartMill fundamental rating of ZOETIS INC (ZTS) stock?

ChartMill assigns a fundamental rating of 7 / 10 to ZTS.


Can you provide the valuation status for ZOETIS INC?

ChartMill assigns a valuation rating of 6 / 10 to ZOETIS INC (ZTS). This can be considered as Fairly Valued.


Can you provide the profitability details for ZOETIS INC?

ZOETIS INC (ZTS) has a profitability rating of 9 / 10.


What are the PE and PB ratios of ZOETIS INC (ZTS) stock?

The Price/Earnings (PE) ratio for ZOETIS INC (ZTS) is 19.06 and the Price/Book (PB) ratio is 15.51.


What is the earnings growth outlook for ZOETIS INC?

The Earnings per Share (EPS) of ZOETIS INC (ZTS) is expected to grow by 10.17% in the next year.